1. Availability of technology for managing cancer patients in the Southeast European (SEE) region. (May 2022) Authors: Dosanjh, Manjit; Ristova, Mimoza; Gershan, Vesna; Georgieva, Petya; Balin Kovacevic, Marijana; Bregu, Ledio; Coralic, Irma; Djurovic, Tamara; Dosieva, Deyana; Foka, Yiota; Fröbe, Ana; Hatziioannou, Konstantinos; Hourdakis, Costas J.; Kabashi, Yllka; Kalev, Dimitar; Kurtishi, Ilir; Litov, Leandar;... Journal: Clinical and translational radiation oncology Issue: Volume 34(2022) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2018) Authors: Di Leo, Angelo; Johnston, Stephen; Lee, Keun Seok; Ciruelos, Eva; Lønning, Per E; Janni, Wolfgang; O'Regan, Ruth; Mouret-Reynier, Marie-Ange; Kalev, Dimitar; Egle, Daniel; Csőszi, Tibor; Bordonaro, Roberto; Decker, Thomas; Tjan-Heijnen, Vivianne C G; Blau, Sibel; Schirone, Alessio; Weber, Denis; ... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cemiplimab‐Behandlung eines Plattenepithelkarzinoms bei einem Patienten mit einer schweren rezessiven dystrophischen Epidermolysis bullosa. (16th March 2023) Authors: Vasilev, Preslav; Kalev, Dimitar; Karamanliev, Martin; Dimitrov, Dobromir; Troyanova, Petranka; Yordanova, Ivelina Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 21:Number 3(2023) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗